Hyperthermia is an important modality in cancer therapy and it is also a powerful sensitizer when used in combination with ionizing radiation. However, its effectiveness is limited by the ubiquitous homeostatic phenomenon of thermotolerance. To identify a strategy which antagonizes thermotolerance, and thereby enhance the effectiveness of hyperthermia as a cancer treatment, it will be necessary to understand the molecular basis of the response. Although the expression of heat shock proteins (HSP), the most highly conserved genetic system known, has long been associated with thermotolerance, their role in this phenomenon is unknown. Recently, it has been shown that the yeast 104 kDa hsp is required for the majority of thermotolerance in that organism. It is the objective of this application to extend these studies to the mammalian homologue of this protein, hsp 110. We have previously shown that this is a nucleolar protein (as is yeast hsp 104) and moreover, that nucleolar function (protected recovery of rRNA synthesis) is required for thermotolerance. To further examine hsp 110, we will clone the mammalian cDNA and use it to construct cells which either over- or under-express hsp 110. These will be used to examine the effect of altered expression of the protein on protection of rRNA synthesis and on heat resistance. We will also purify hsp 110 and analyze its structure and function using biochemical and microinjection techniques. The effect of hsp 110 on the efficiency of rRNA synthesis will be examined in an in vitro transcription system, by addition or removal of active hsp 110. The common nucleolar localization of the approximately 110 kDa hsp in yeast and mammalian cells argues that the function of these proteins is conserved. This study will determine if this is the case and will define the role of hsp 110 in mammalian thermotolerance.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM045994-02
Application #
3305493
Study Section
Radiation Study Section (RAD)
Project Start
1992-02-01
Project End
1996-01-31
Budget Start
1993-02-01
Budget End
1994-01-31
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Wang, Xiang-Yang; Manjili, Masoud H; Park, Juneui et al. (2004) Development of cancer vaccines using autologous and recombinant high molecular weight stress proteins. Methods 32:13-20
Wang, Xiang-Yang; Kazim, Latif; Repasky, Elizabeth A et al. (2003) Immunization with tumor-derived ER chaperone grp170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease. Int J Cancer 105:226-31
Wang, Xiang-Yang; Chen, Xing; Manjili, Masoud H et al. (2003) Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100. Cancer Res 63:2553-60
Ostberg, J R; Kaplan, K C; Repasky, E A (2002) Induction of stress proteins in a panel of mouse tissues by fever-range whole body hyperthermia. Int J Hyperthermia 18:552-62
Manjili, Masoud H; Henderson, Robert; Wang, Xiang-Yang et al. (2002) Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110. Cancer Res 62:1737-42
Wang, Xiang-Yang; Li, Ying; Manjili, Masoud H et al. (2002) Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor. Cancer Immunol Immunother 51:311-9
Wang, X Y; Kazim, L; Repasky, E A et al. (2001) Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. J Immunol 166:490-7
Hylander, B L; Chen, X; Graf, P C et al. (2000) The distribution and localization of hsp110 in brain. Brain Res 869:49-55
Henics, T; Nagy, E; Oh, H J et al. (1999) Mammalian Hsp70 and Hsp110 proteins bind to RNA motifs involved in mRNA stability. J Biol Chem 274:17318-24
Oh, H J; Easton, D; Murawski, M et al. (1999) The chaperoning activity of hsp110. Identification of functional domains by use of targeted deletions. J Biol Chem 274:15712-8

Showing the most recent 10 out of 19 publications